[5] [17] Symptoms of hypoglycemiaincluding confusion, excessive sweating, tremor, rapid heartbeat, or loss of consciousnessrequire immediate intervention, especially in patients taking concurrent insulin or sulfonylureas
In this longer-term study patients who had responded to VYVANSE in the preceding 12-week open-label treatment phase were randomized to continuation of VYVANSE or placebo for up to 26 weeks of observation for relapse
Headache was reported as an adverse event during treatment with liraglutide, semaglutide, phentermine/topiramate, and naltrexone/bupropion, though it was not a severe adverse event
Obesity: Identification, assessment and management
In most cases, eligibility can be determined after an initial consultation with a licensed provider
Older adults are more likely to be on multiple medications, increasing the potential for interactions